Integrating GC–MS Phytochemical Profiling and In Vivo Pharmacological Evaluation to Reveal the Antidiabetic Potential of the Ethanolic Extract of Scleria sumatrensis Retz. in Alloxan-Induced Diabetic Rats. / Integrasi Profil Fitokimia Berbasis GC–MS dan Evaluasi Farmakologis In Vivo dalam Menilai Potensi Antidiabetes Ekstrak Etanol Scleria sumatrensis Retz. pada Model Tikus Diabetes Induksi Aloksan.

This study evaluated the antidiabetic activity and phytochemical profile of the ethanolic extract of Scleria sumatrensis Retz. Using an alloxan-induced diabetic rat model. Diabetes was induced by a single intraperitoneal injection of alloxan (150 mg/kg BW) after a 12-hour fasting period, and fasting blood glucose was measured at three standardized time points: GD1 (baseline), GD2 (72 hours post-induction), and GD3 (day 14 post-treatment). GC–MS analysis revealed several major constituents, including ethyl α-D-glucopyranoside, ethyl linoleate, ethyl linolenate, phytol, tocopherol, and β-sitosterol, which are associated with improved insulin sensitivity, modulation of PPAR-γ–related pathways, antioxidant protection of pancreatic β-cells, and reduced intestinal carbohydrate digestion. Rats were assigned to negative control (vehicle), positive control (metformin 45 mg/kg BW), and extract-treated groups (75, 150, and 300 mg/kg BW). Percentage reduction from GD2 to GD3 was analyzed using one-way ANOVA followed by Tukey’s post-hoc test. The extract produced a significant and dose-dependent decrease in fasting glucose (p < 0.001). All extract doses differed significantly from the negative control, and the 300 mg/kg dose demonstrated glucose-lowering efficacy comparable to metformin. These findings indicate that Scleria sumatrensis possesses vigorous antihyperglycemic activity consistent with its lipophilic phytochemical composition. Further studies are required to verify the underlying mechanisms and identify the most active constituents.

Penelitian ini mengevaluasi aktivitas antidiabetes dan profil fitokimia ekstrak etanol Scleria sumatrensis Retz. menggunakan model tikus diabetes induksi aloksan. Diabetes diinduksi dengan injeksi intraperitoneal aloksan (150 mg/kgBB) setelah puasa 12 jam, dan kadar glukosa darah puasa diukur pada GD1 (sebelum induksi), GD2 (72 jam setelah induksi), dan GD3 (hari ke-14 perlakuan). Analisis GC–MS mengidentifikasi beberapa senyawa utama, termasuk ethyl α-D-glucopyranoside, ethyl linoleate, ethyl linolenate, phytol, tokoferol, dan β-sitosterol, yang diketahui berperan dalam peningkatan sensitivitas insulin, modulasi jalur PPAR-γ, perlindungan antioksidan terhadap sel β pankreas, serta penghambatan pencernaan karbohidrat. Tikus dibagi menjadi kelompok kontrol negatif (vehicle), kontrol positif (metformin 45 mg/kgBB), dan perlakuan ekstrak (75, 150, dan 300 mg/kgBB). Persentase penurunan glukosa dari GD2 ke GD3 dianalisis menggunakan ANOVA satu arah dan uji lanjut Tukey. Ekstrak menunjukkan penurunan glukosa yang signifikan dan bergantung dosis (p < 0.001). Semua dosis ekstrak berbeda signifikan dari kontrol negatif, dan dosis 300 mg/kgBB menunjukkan efektivitas sebanding dengan metformin. Hasil ini menunjukkan bahwa Scleria sumatrensis memiliki aktivitas antihiperglikemia yang kuat, konsisten dengan komposisi fitokimianya. Studi lanjutan diperlukan untuk memverifikasi mekanisme dan mengidentifikasi senyawa aktif utamanya.